>>> US After Hours Summary: GERN +16.5% on ime

After Hours Summary: GERN +16.5% on imetelstat Fast Track designation, FPRX / SLG lower following analyst downgrades

After Hours Gainers:

Companies trading higher in after hours in reaction to news: GERN +16.5% (announces Fast Track designation granted to imetelstat for relapsed/refractory myelofibrosis), IOVA +0.9% (initiated with a Buy at Stifel)

After Hours Losers:

Companies trading lower in after hours in reaction to news: ANAB -13.5% (reports topline data from interim analysis of GALLOP Phase 2 clinical trial of ANB019 monotherapy in moderate-to-severe generalized pustular psoriasis), FPRX -1.2% (downgraded to Neutral from Buy at Guggenheim), SLG -0.6% (downgraded to Hold from Buy at Stifel)